First International Electronic Conference on Synthetic Organic Chemistry (ECSOC-1), www.mdpi.org/ecsoc/, September 1-30, 1997
[A0011]

Synthesis and Biological Evaluation of 14 b-Methoxy Digitalis Derivatives

M. Gobbini, N. Almirante, A. Cerri, G. Padoani, and P. Melloni
Prassis Istituto di Ricerche Sigma-Tau, Via Forlanini, 3, Settimo Milanese (MI), Italy

Received: 9 July 1997 / Uploaded: 21 July 1997


Introduction

Digitalis cardiac glycosides are well known drugs clinically used for treatment of congestive heart failure.1 Their action is mainly due to inhibition of Na+,K+-ATPase, an enzyme located in the cell membrane and promoting the outward transport of Na+ and the inward transport of K+.2 Recently the existence of endogenous digitalis-like factors that may be responsible for essential hypertension3 has opened a new field in the study of compounds acting on the Na+,K+-ATPase. The most potent inhibitors of Na+,K+-ATPase are cardenolides such as digitoxigenin (Figure 1) with the following structural characteristics: 17b-unsaturated lactone, 3b- and 14b-hydroxy substituents and A/B and C/D cis ring junctions. The 14b-hydroxy group is involved in a hydrogen bonding with the receptor and plays an important role in binding digitalis compounds to Na+,K+-ATPase receptor; in fact compounds in which this group is absent show very low binding affinity or no affinity at all.4 However the known derivatives with a 14b,15b-epoxy group (Figure 1) show high binding affinities although not as high as the 14b-hydroxy analogues (Table 1).



Figure 1. Known compounds synthesized using the reported procedures.

Herein, we report the synthesis and biological evaluation of unknown 14b-methoxy derivatives of digitoxygenin and of other digitalis-like compounds. These compounds have a 14b-oxygen, which can be a hydrogen bonding acceptor, as is the case of 14b,15b-epoxide derivatives, but not a hydrogen bonding donor as is the case of 14b-hydroxy derivatives. Comparison of the binding values of these three classes of compounds could allow more insight into the requirements necessary for recognition by the receptor. Only a 3b-glucoside derivative of 14b-methoxydigitoxygenin has been described;10 for which the inotropic activity was reported to be marginal, but no synthetic route was given.

Chemistry

Attemps to introduce a methyl on the 14b-hydroxy group of digitoxigenin, with the secondary 3b-hydroxy protected, using diazomethane or dimethyl sulfate failed; diazomethane failed also when applied on the 17b-(3-furyl) analogue, while dimethyl sulfate gave low yield.
We then turned our attention to a Williamson reaction with MeI and, since the strongly basic reaction conditions proved incompatible with the presence of the
a,b-unsaturated lactone of digitoxigenin, we tried the reaction on the17b-furyl derivative 2 (Scheme 1).


Scheme 1. Reagents and conditions: a: tert-butyldimethylsilyl chloride, TEA, DMF, rt (90%); b: KH, dry THF, reflux; then MeI; c: n-Bu4NF, THF, reflux (quantitative from 2).

The known 17b-(3-furyl)-5b-androstane-3b,14b-diol 111 was reacted with tert-butyldimethylsilyl chloride in DMF in the presence of triethylamine to give the protected derivative 2 (90%); this TBS derivative and KH were kept at reflux temperature for one hour in dry THF; the addition of MeI instantaneously gave the desired 14b-methoxy derivative 3a. The crude 3a was deprotected with n-Bu4 NF in THF at reflux temperature to give 3b in quantitative yield from 2.
From the 14
b-methoxy derivative 3a the 14b-methoxy digetoxigenin 6b could be obtained by the oxidative/reductive procedure6 shown in Scheme 2. The crude 3a was reacted with m-chloroperbenzoic acid in CHCl3 in the presence of AcOH and AcONa; the crude hydroxy lactone intermediates 4a and 5a were reduced with NaBH4 in CH2Cl2 to give a mixture of the desired digitoxigenin derivative 6a and of the isomeric isodigitoxigenin derivative 7a in a 8:2 ratio. The two compounds were separated by flash chromatography to give 6a (49% from 2) and 7a (13% from 2) and then deprotected by acidic hydrolysis with dil. HCl in a CHCl 3/MeOH mixture; 6b (81%) and 7b (58%).
12



Scheme 2. Reagents and conditions: a: m-chloroperbenzoic acid, AcOH, AcONa, CHCl3, rt; b: NaBH4, CH2Cl2, rt, (6a 49%; 7a 13%); c: 5% aq. HCl, CHCl 3/MeOH, rt (6b 81%; 7b 58%).

The 17b-(4-pyridazinyl) derivative 8a was prepared by reacting the 17b-(3-furyl) derivative 3a with NBS in THF in the presence of AcONa and then with hydrazine7 to give, after chromatographic purification, the desired 8a (24% from 2) and the N-amino lactam derivative 9a as a side product (20% from 2); 8a was deprotected with n-Bu4 NF in THF at reflux temperature (81% yield), while 9a degraded to a complex mixture under the same conditions.


Scheme 3. Reagents and conditions: a: NBS, AcONa, THF, 5 deg.C; then hydrazine, water, rt, (8a 24%; 9a 20%); b: n-Bu4NF, THF, reflux (8b 81%; 9b degradation).

Biological Data

All the synthesized compounds were evaluated, in comparison with 14b,15b-epoxy and/or 14b-hydroxy analogues, for displacement of the specific [3H]-ouabain binding13 on Na+,K+-ATPase (Table 1).

Table 1

Compound
Bindinga
Compound
Bindinga
Digitoxigenin
7.2
17b-(3-furyl) derivative 1
6.6
Digitoxigenin 14b,15b-epoxy
6.6
17b-(3-furyl)-14b,15b-epoxy
5.2
Digitoxigenin 14b-methoxy 6b
5.4
17b-(3-furyl)-14b-methoxy 3b
4.3
Isodigitoxigenin
5.4
17b-(4-pyridazinyl) derivative
7.0
Isodigitoxigenin 14b-methoxy 7b
17% at 10-4M
17b-(4-pyridazinyl)-14b-methoxy 8b
4.9

aAverage of three values (-log IC50). The affinity for the receptor site of Na+,K+-ATPase was evaluated by the displacement of the specific [3H]-ouabain binding from Na+,K+-ATPase receptor13a isolated from dog kidney and purified according to Jørghensen.13b

All the new 14
b-methoxy derivatives show a considerable reduced binding affinity when compared with the 14b-hydroxy analogues and also with the 14b,15b-epoxy derivatives; the reduction in the affinity varies from 65 times for 6b, the most potent 14b-methoxy derivative, to 200 times for 3b; the 14b-methoxy derivative of isodigitoxigenin 7b was almost devoid of any affinity. These results could mean that the digitalis receptor does not permit the presence of a bulky substituent in the 14b region, even of relatively small volume like the methyl group. In fact the reduced binding affinities of the 14b-methoxy derivatives do not seem to depend on the impossibility of being hydrogen donors since the two epoxy derivatives reported in Table 1 show high binding affinity although lower than that of the 14b-hydroxy analogues.


References and Notes

  1. Hofman, B. F.; Bigger, J. T. In The Pharmacological Basis of Therapeutics; Goodman Gilman, A.; Nies, A. S.; Rall, T. W.; Taylor, P., Eds.; Pergamon Press, New York, 1990, Section VII, Chapter 34.
  2. Repke, K. R. H.; Schönfeld, W. Trends Pharmacol. Sci., 1984, 5, 393.
  3. Schoner, W. Trends Pharmacol. Sci., 1991, 12, 209.
  4. Thomas, R.; Gray, P.; Andrews, J. Adv. Drug Res., 1990, 19, 312.
  5. Yamada, A. Chem. Pharm. Bull., 1960, 8, 18.
  6. Ferland, J. M.; Lefebvre, Y.; Deghenghi, R.; Wiesner, K. Tetrahedron Letters, 1966, 3617.
  7. Siphar S.A., DE 2,534,981; CA 85:33365f.
  8. Engel, C. R.; Bach, G. Steroids, 1964, 3, 593.
  9. Yoshii, E.; Koizumi, T.; Mizuno, S.; Kitatsuji, E. Chem. Pharm. Bull., 1976, 24, 3216.
  10. Pastelin, G.; Mendez, R. Arch. Farmacol. Toxicol., 1984, 10, 135.
  11. Minato, H.; Nagasaki, T. J. Chem. Soc., 1966, 377.
  12. Use of n-Bu4NF was incompatible with the presence of the a,b-unsaturated lactones; during the acidic hydrolysis the 14-unsaturated side products were formed: less than 10% for 4a and 30% for 5a.
  13. a) Brown, L.; Erdmann, E. Arzneim. Forsh., 1984, 34, 1314. b) Jørghensen, P. L. Biochim. Biophys. Acta, 1990, 19, 312.


All comments on this poster should be sent by e-mail to ecsoc@listserv.arizona.edu with A0011 as the message subject of your e-mail.